Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)

Effects of E-Cigarettes on the Lung Metabolome in People Living With HIV

NCT04794543•Pennington Biomedical Research Center

Summary

This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and to test novel interventions to mitigate vaping's contribution to acute and/or chronic lung injury.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•documented HIV-infection
•in care at an HIV specialty clinic
•age ≥ 18 years.

Exclusion Criteria

•a pacemaker or other implanted electronic device
•pregnant women, prisoners, cognitively-impaired subjects.
•For this ancillary, the experimental group must actively use at least one of the following: e-cigarettes, e-liquid vapes, burning leaf tobacco cigarettes, or inhaled burning leaf marijuana (cannabis). The control group will have no use of e-cigarettes or vape or active smoking in the past year.
•Participants must be willing to archive data and biological samples for future use.
•Exclusion from the ancillary are:
•overt respiratory or oral cavity disease
•acute illness in the past 4 weeks
•active cancer
•active weight loss program
•any other medical, psychiatric or behavioral factors that, in the judgment of the PI may interfere with study participation or ability to follow the protocol

Locations (2)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States

Lsuhsc-No

New Orleans, Louisiana, United States

Key Dates

Start Date

April 1, 2022

Primary Completion Date

August 31, 2023

Completion Date

December 4, 2023

Last Updated

August 26, 2024

Enrollment

ACTUAL participants

Conditions

HivLung Injury

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

View study

RECRUITING

Thinking and Memory Problems in People With HIV

NCT01875588

HIV Positive

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 26, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)

Inclusion Criteria

Exclusion Criteria

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Thinking and Memory Problems in People With HIV

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption